Rockford Distribution Fund

• Rockford Funding Group has agreed to a settlement in a class action suit brought by the Securities and Exchange Commission.
• Clients who invested funds with Rockford between March and November of 2009 are potential claimants.
• The SEC found that Rockford obtained millions dollars in a deliberately fraudulent manner, effectively stealing from hundreds of customers. At the time it was soliciting clients, Rockford claimed it was one of the most established investment firms in the country – even though it was just a few years old.

According to the lawsuit, the SEC found that Rockford was essentially running a Ponzi scheme. In other words, Rockford was funding clients’ accounts using the money of new investors.

Important Information

• The settlement fund currently contains approximately six hundred thousand dollars.
• In order to claim compensation, settlement members must provide statements, receipts, and other documentation that they invested funds with Rockford.
• Settlement members must submit a claim form if they wish to receive compensation. It is the responsibility of the settlement members to ensure their claim forms are received.
• The deadline is coming up quickly. Class members must submit a claim by 10 August 2015.

If you file to receive a payout under this class action settlement, you relinquish your right to sue Rockford yourself. Once you accept your pay, you cannot bring your own suit against Rockford to recover any damages relating to this incident.

How to File

• Settlement members must obtain a claim form online at rockforddistribution.com
• Claim forms must be sent via mail. At this time, there is no way to submit a form online
• Make sure you submit proof of your investments along with your claim form.
• Claim forms must be mailed to the following address: SEC v Rockford Funding Group, LLC, et al. c/o Analytics, P.O. Box 2002, Chanhassen, MN 55317

Claimants can expect to receive compensation funds in early 2016. If you have any questions or have trouble filing a claim, contact the claims administrator.

Citations

• www.rockforddistributionfund.com

Beck’s Beer Settlement

•  Marty v. Anheuser Busch, which was filed in response to several concerns regarding the Beck’s Beer brand, is currently pending in court.
• According to the suit, Anheuser Busch has implied that it’s Beck’s Beer brand is imported from Europe, and charges import prices even though the beer is brewed domestically.
• Anheuser Busch has responded that it hasn’t done anything illegal or dishonest.

The lawsuit continues to state that the brewing company is generating unjust profits based on misrepresentation and dishonesty. At this time, the settlement claim is only a proposal, and has not been finalized in court at this time.

Important Information

•  Per the terms of the settlement, class members will receive anywhere between $0.10 and $1.75 for every Beck’s Beer product purchased within a specified time frame.
• Claimants don’t need proof of purchase to get their compensation. However, if class members can’t furnish proof of purchase, the court will cap their reward at a maximum of $12.00.
• No maximum payout is specified as long as class members can provide proof of purchase.
• Class members may include any customer who has purchased a Beck’s Beer product between 1 May 2011 and 23 June 2015.

Class members must complete a claims form to receive payment. Always remember that if you file for a reward as a class member, you relinquish your right to bring your own suit against Anheuser Busch regarding this issue.

Claims Administration Information

•  Class members who wish to object to the settlement must file with the Court no later than 29 September 2015.
• The final hearing, which will iron out and finalize the details of the settlement, will take place on 20 October.
• Settlement members who wish to claim compensation must submit a claims forms by 20 November.
• Settlement members can file claims via mail, or online at www.beckersbeersettlement.com

Filing online is the simplest and most effective way to ensure you submit your claim form by the deadline. If you have trouble completing the claim form, or simply want more information regarding the settlement, call 888-881-0318 as soon as possible.

Citations

• www.becksbeersettlement.com

Nexium Case Antitrust Settlement

•  A current, pending lawsuit claims that four Nexium drug manufacturers violated U.S. Antitrust laws by intentionally delaying the availability of generic Nexium drugs
• Several parties are named as defendants in the suit, including the pharmaceutical manufacturers AstraZeneca, Teva, Dr. Reddy’s, and Ranbaxy
• Teva and Dr. Reddy’s have already reached settlements with the court. Neither Ranbaxy or AstraZeneca plan to settle at this time.

According to the lawsuit, the four drug manufacturers deliberately disturbed generic competition for their drug, Nexium. This caused customers in several states to overpay for Nexium.

Important Information

•  Only two of the defendants have settled. The other two, AstraZeneca and Ranbaxy, are still in the litigation process.
• The court hasn’t decided what, if any, compensation will be awarded to class members.
• At this time, the Claims Administrator hasn’t provided any claim forms.
• The lawsuit specifically concerns violation of Antitrust Legislation, and has no bearing on the efficacy or safety of Nexium.

While class members don’t yet have the option to file for a claim, it’s important to remember that customers who receive a settlement payment forfeit the right to bring their own suits against any of the defendants.

Claims Administration Information

• Class members who wish to object to the settlement must file with the Court by 10 August 2015
• The final hearing, which will determine whether or not the settlement takes affect, will occur on 29 September 2015
• There is currently no information on when class members can expect to file a claim or receive compensation.

The lawsuit is still pending. Teva and Dr. Reddy settled in December 2014. The courts initially ruled in favor of Ranbaxy and AstraZeneca, but the original plaintiffs have already filed for a new trial. As the suit proceeds, more information will be made available.

Citations

• www.nexiumcase.com